This promises to be another worthwhile event with appeal to many Drug Channels readers. The conference speakers include executives from both pharmaceutical manufacturers and wholesalers. Topics include pedigree, brand protection, cargo theft, anti-counterfeiting, and other related topics. These subjects are especially timely given the news that Bristol-Myers Squibb suffered a major in-transit cargo theft last Thursday.
As always, CBI provides a valuable forum for networking and sharing of best practices, so I encourage you to check out this event.
OFFICIAL DESCRIPTION FROM CBI
Life Science Finished Product Supply Chain Summit
In-Transit Security * ePedigree * Cold Chain Management
No matter how diligent and tight your supply chain processes are, the chance of a product being tampered, damaged or stolen always remains. With over $97 million worth of drugs stolen last year, government agencies and news outlets have been stepping up the scrutiny placed on the distribution networks of drug manufacturers. Due to this scrutiny, the finished product supply chain has become a complex and difficult environment to operate within. This summit allows you to examine all of the challenges faced when trying to move a product from the manufacturer to the patient/facility.
Attend session focusing on three main themes in the area of finished product supply chain:
- In-Transit Security
- Cold Chain Management
- Anti-counterfeiting and ePedigree
Don’t miss this opportunity to navigate regulatory and market pressures affecting your supply chain, learn from a panel of your peers in a town-hall discussion and listen to a cross-industry perspective on cargo-security excellence. For more information or to register, visit www.cbinet.com/finishedproduct, call 800-817-8601 or email email@example.com.